[Pulmonary diffusion of carbon monoxide in 2 clinical situations: bronchial asthma and diabetes mellitus]

An Med Interna. 2001 May;18(5):237-42.
[Article in Spanish]

Abstract

Objective: The aim of our work has been the study and comparison of diffusion capacity of CO (DLCO) in two different clinical situations: bronchial asthma and diabetes mellitus.

Method: We have studied 16 control subjects, 38 patients with bronchial asthma and 65 patients with diabetes mellitus. We performed CO pulmonary diffusion tests by single breath method to determine two components: membrane diffusion factor (Dm) and pulmonary capillary blood volume (Vc).

Results: We have found a positive correlation of FEV1 with Dm. The bronchial asthma group had a lower FEV1 and FEF25-75% and an increase in DLCO, Dm and Vc, with respect to the control group. The diabetes mellitus group presented a decrease in CVF, FEV1, DLCO and Vc, with respect to the control group. The bronchial asthma group showed a lower ratio of Dm/Vc than the control and diabetes groups.

Conclusions: The bronchial asthma patients have an increase in CO pulmonary diffusion, membrane diffusion factor and pulmonary capillary volume. However, the diabetes mellitus patients present a decrease in CO pulmonary diffusion mainly due to pulmonary capillary volume.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Aged
  • Asthma / metabolism*
  • Carbon Monoxide / pharmacokinetics*
  • Diabetes Mellitus / metabolism*
  • Diffusion
  • Female
  • Humans
  • Lung / physiology*
  • Male
  • Middle Aged

Substances

  • Carbon Monoxide